439133-67-2

Usage

Uses

Used in Pharmaceutical Development:
(S)-2-Amino-5-methoxytetralin (S)-mandelate is utilized as a precursor in the development of new pharmaceuticals targeting central nervous system disorders. Its high receptor affinity and selectivity make it a promising candidate for creating medications that can effectively manage symptoms associated with Parkinson's disease, schizophrenia, and depression.
Used in Neurological Disorder Treatment:
In the field of neurology, (S)-2-Amino-5-methoxytetralin (S)-mandelate is employed as a potential therapeutic agent for the treatment of Parkinson's disease. Its interaction with dopamine receptors suggests it may help alleviate motor symptoms and improve the quality of life for patients suffering from this condition.
Used in Psychiatric Disorder Management:
(S)-2-Amino-5-methoxytetralin (S)-mandelate is also used in psychiatry as a potential treatment for psychiatric disorders such as schizophrenia and depression. Its modulation of serotonin and dopamine receptor activity could contribute to the regulation of mood and behavior, offering new treatment options for these complex mental health conditions.
Used in Drug Stability and Bioavailability Enhancement:
The (S)-mandelate salt form of the compound is used to improve the stability and bioavailability of (S)-2-Amino-5-methoxytetralin, making it a more viable candidate for pharmaceutical applications. This enhancement is crucial for the compound's effectiveness and safety in clinical settings, ensuring that it can be delivered efficiently to target receptors within the body.